AzTrials
AzTrials

Whey ProteinNCT06035510

Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery

A study testing whey protein supplement in people with Whey Protein and Postoperative Outcomes, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Major surgeries including gynecological cancer surgery can make surgical stress that leads to increased burden of postoperative complications, delayed length of hospital stay and increased mortality rate. Read more about this study

Who is it for?
Ages 18 to 70 years, women onlyHealthy volunteers can take part
What is being tested?
whey protein supplement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteThailand
Study dates
21 Aug 2023to 31 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • A Woman who suspected or diagnosed with ovarian and endometrial Cancer
  • A Woman who candidates for elective Surgical staging of Laparotomy operation in Rajavithi hospital
  • Aged 18-70 years old
  • Can communicate and understand Thai language very well
  • A woman voluntarily participated in the research

Who cannot join

  • Allergy to whey protein and protein product such as cow milk and egg
  • A Woman who diagnosed with Hypertension, Diabetes Mellitus, Chronic Kidney Disease, Heart disease and Chronic liver disease
  • A Woman who expected difficult operation such as severe pelvic adhesion or required other surgeon for co-evaluation
  • Pregnant woman or breastfeeding
  • A Woman who denied surgery
  • A Woman who currently take a protein supplement
  • A Woman who take Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) , Bisphosphonates, Levodopa ,Tetracycline and Quinolone

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Rajavithi

    Phaya Thai, ratchathewi, 10400

Other trials in Thailand

About this study

Major surgeries including gynecological cancer surgery can make surgical stress that leads to increased burden of postoperative complications, delayed length of hospital stay and increased mortality rate. Protein is one of the essential factors that contribute to the recovery of patients following surgery, as the surgical process increases protein breakdown in the body. Providing patients with an adequate amount of protein helps enhance muscle building, aids in muscle repair, and reduces postoperative inflammation.

One study administered a fluid containing a combination of whey protein and carbohydrates to cancer patients in preoperative and postoperative periods. The result of the study shows that intervention group can reduce the length of hospital stay and postoperative complications.

However, studies focusing on the use of only-protein supplement to improve surgical complications in gynecological cancer patients are limited. This study aims to investigate the administration of protein supplement before and after surgery in gynecological cancer patients its contribution to the reduction of length of hospital stay and postoperative complications at Rajavithi Hospital.

Read the detailed description

During admission, Participants will be randomized by a computer program into two groups as the whey protein supplement group and control group. Both groups will undergo nutritional assessment on the first day of admission before surgery by the Rajavithi Subjective Global Assessment tool and serum albumin level.

The whey protein supplement group : participants will receive isolated whey protein in the form of two packets of isolated whey protein powder (each packet containing 11.5 grams, totaling to 23 grams) mixed with water in a 350 milliliter drinking bottle at 6.00 p.m. on first day before operation. After the operation, participants will receive the same form of protein supplement as before surgery at 6.00 a.m. on the first day after operation.

The control group : participants will receive standard care, which includes fasting from food after midnight on the night before surgery and other standard surgical protocols.

After surgery, participants will be assessed based on

  1. Intraoperative outcomes, which include the duration of surgery, intraoperative blood loss, and intraoperative complications.
  2. The postoperative outcomes, which include length of hospital stay, duration of stay in the intensive care unit (ICU), postoperative complications, postoperative pain, time to first ambulation , time to first flatus , nausea and vomiting symptoms, increased requests for pain medication, fever more than 24 hours after surgery , wound infection and readmission.
  3. The nutritional status outcomes, assessed through serum albumin levels before surgery and on the 3rd day after surgery in both groups of participants.
  4. The side effects of whey protein supplement, in the experimental group participants, which will evaluate include allergic reactions, nausea, vomiting, abdominal discomfort, bloating, headache, reduced appetite, elevated creatinine levels, and increased liver function levels on the 3rd day and two weeks after surgery.
Being tested
whey protein supplement
Keywords
Whey Protein, Postoperative outcomes, Gynecological Cancer Surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • whey protein supplementDietary supplement

    Participants are given Isolated whey protein supplement in evening before surgery and first day of post operation to compare with standard operative care on postoperative outcomes after gynecological cancer surgery

Study groups in NCT06035510
Study groupRoleWhat they receive
whey protein supplementExperimentalParticipants are given lactose-free Isolated whey protein 23 gm (containing with whey protein isolate 98.7 % ,Soya lecithin 1.3 % ) which mixed with water 350 ml at 6 p.m prior to surgery and 6.00 a.m. at first day after post surgery
Receives: Dietary Supplement: whey protein supplement
standard operative careNo interventionParticipants followed standard operative care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of post-operative hospital stay

    Length of post-operative hospital stay after operation to discharged

    Measured: an average of 3 days after operation

Secondary outcomes (14)
  1. operative time

    To compare operative time between intervention group and control group

    Measured: start to end of operation, an average of 3 hours

  2. ICU admission

    Length of ICU admission after operation

    Measured: an average of 3 days after operation

  3. number of wound infection

    To compare number of wound infection after operation

    Measured: 1 and 2 week after operation

  4. Readmission

    To compare readmission between intervention group and control group

    Measured: 1 month after operation

  5. Level of serum albumin

    To compare serum albumin before operation and after operation

    Measured: one day before operation and 3 day after operation

  6. Side effect of protein supplement

    To study the side effect of protein supplement

    Measured: 3 day and 2 week after operation

  7. Unit of blood transfusion

    To compare unit of blood transfusion during operation between intervention group and control group

    Measured: start to end of operation, an average of 3 hours

  8. Intraoperative complication

    To compare intraoperative complication

    Measured: start to end of operation, an average of 3 hours

  9. postoperative complication

    To compare postoperative complication between intervention group and control group

    Measured: Any events occur within 14 days

  10. Level of pain score

    To compare postoperative pain score

    Measured: up to 3 days after operation

  11. time of first ambulation

    To compare time of first ambulation after operation

    Measured: up to 3 days after operation

  12. time of first flatus and defecation

    To compare time of first flatus and defecation after operation

    Measured: up to 3 days after operation

  13. Number of additional pain control drug

    To compare Number of additional pain control drug after operation

    Measured: up to 3 days after operation

  14. Body temperature

    To compare post operative fever after operation

    Measured: Any events occur within 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2023
  2. Study start21 Aug 2023
  3. Primary completion31 Oct 2024
  4. Study completion31 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06035510
Sponsor's protocol ID
143/2556
Status last verified
Aug 2023
First submitted
21 Aug 2023
Last updated
14 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing whey protein supplement in people with Whey Protein and Postoperative Outcomes, run by Department of Medical Services Ministry of Public Health of Thailand at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of post-operative hospital stay (time frame: an average of 3 days after operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in